Page last updated: 2024-10-27

flufenamic acid and Stevens-Johnson Syndrome

flufenamic acid has been researched along with Stevens-Johnson Syndrome in 1 studies

Flufenamic Acid: An anthranilic acid derivative with analgesic, anti-inflammatory, and antipyretic properties. It is used in musculoskeletal and joint disorders and administered by mouth and topically. (From Martindale, The Extra Pharmacopoeia, 30th ed, p16)
flufenamic acid : An aromatic amino acid consisting of anthranilic acid carrying an N-(trifluoromethyl)phenyl substituent. An analgesic and anti-inflammatory, it is used in rheumatic disorders.

Stevens-Johnson Syndrome: Rare cutaneous eruption characterized by extensive KERATINOCYTE apoptosis resulting in skin detachment with mucosal involvement. It is often provoked by the use of drugs (e.g., antibiotics and anticonvulsants) or associated with PNEUMONIA, MYCOPLASMA. It is considered a continuum of Toxic Epidermal Necrolysis.

Research Excerpts

ExcerptRelevanceReference
"This is the first case of toxic epidermal necrolysis because of treatment with etofenamate of which we are aware."1.36Etofenamate associated with Lyell syndrome: a case report. ( Atilla, OD; Golcuk, Y; Oray, D; Tefennioglu, N, 2010)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Golcuk, Y1
Oray, D1
Atilla, OD1
Tefennioglu, N1

Other Studies

1 other study available for flufenamic acid and Stevens-Johnson Syndrome

ArticleYear
Etofenamate associated with Lyell syndrome: a case report.
    Clinical toxicology (Philadelphia, Pa.), 2010, Volume: 48, Issue:5

    Topics: Awareness; Female; Flufenamic Acid; Humans; Middle Aged; Risk Factors; Stevens-Johnson Syndrome

2010